Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Evolent Health, Inc. (EVH) is the issuer whose Class A shares are covered by an amended Schedule 13G: Cadian Capital Management, LP, its general partner Cadian Capital Management GP, LLC, and Eric Bannasch, the GP’s sole managing member, each may have been deemed to beneficially own 509,464 shares as of September 30, 2026. The shares were directly held by Cadian Master Fund L.P. and Cadian Opportunities Master Fund LP. Cadian Capital Management, LP exercises exclusive voting and investment power under investment management agreements. Each reporting person reported shared voting and dispositive power over 509,464 shares and zero sole power. The reported position was approximately 0.5% of the class, based on 113,059,335 shares outstanding as of August 1, 2026.
Key Figures
Beneficially owned shares:509,464 sharesClass ownership:Approximately 0.5%Class A shares outstanding:113,059,335 shares+1 more
4 metrics
Beneficially owned shares509,464 sharesEach reporting person may have been deemed to beneficially own this amount as of September 30, 2026; the shares were held by two advisory clients.
Class ownershipApproximately 0.5%Each reporting person’s reported beneficial ownership as of September 30, 2026.
Class A shares outstanding113,059,335 sharesOutstanding as of August 1, 2026, as disclosed in Evolent Health’s Form 10-Q.
Sole voting and dispositive power0 sharesEach reporting person’s reported power as of September 30, 2026.
"may have been deemed to have beneficially owned 509,464 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powertechnical
"Shared Voting Power 509,464.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powertechnical
"Shared Dispositive Power 509,464.00"
Investment Management Agreementstechnical
"Pursuant to Investment Management Agreements between the Advisory Clients and the Adviser"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many EVH shares did Cadian report beneficially owning?
Each reporting person may have been deemed to beneficially own 509,464 shares of Evolent Health Class A Common Stock as of September 30, 2026. The shares were directly held by Cadian Master Fund L.P. and Cadian Opportunities Master Fund LP.
What voting power did the EVH ownership report disclose?
Each reporting person reported shared voting and dispositive power over 509,464 shares, with zero sole voting or dispositive power, as of September 30, 2026. Cadian Capital Management, LP exercises exclusive voting and investment power over securities held directly by the two advisory clients under investment management agreements.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Evolent Health, Inc.
(Name of Issuer)
Class A Common Stock, par value $0.01 per share
(Title of Class of Securities)
30050B101
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
30050B101
1
Names of Reporting Persons
Cadian Capital Management, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
509,464.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
509,464.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
509,464.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.5 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
30050B101
1
Names of Reporting Persons
Cadian Capital Management GP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
509,464.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
509,464.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
509,464.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.5 %
12
Type of Reporting Person (See Instructions)
OO, HC
SCHEDULE 13G
CUSIP Number(s):
30050B101
1
Names of Reporting Persons
Eric Bannasch
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
509,464.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
509,464.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
509,464.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.5 %
12
Type of Reporting Person (See Instructions)
IN, HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Evolent Health, Inc.
(b)
Address of issuer's principal executive offices:
1812 North Moore Street, Suite 1705, Arlington, Virginia 22209
Item 2.
(a)
Name of person filing:
(i) Cadian Capital Management, LP, (ii) Cadian Capital Management GP, LLC, and (iii) Eric Bannasch (collectively, the "Reporting Persons").
(b)
Address or principal business office or, if none, residence:
For each of the Reporting Persons: 535 Madison Avenue, 36th Floor, New York, New York 10022.
(c)
Citizenship:
(i) Cadian Capital Management, LP is a Delaware limited partnership, (ii) Cadian Capital Management GP, LLC is a Delaware limited liability company, and (iii) Eric Bannasch is a United States citizen.
(d)
Title of class of securities:
Class A Common Stock, par value $0.01 per share
(e)
CUSIP No.:
30050B101
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of September 30, 2026, each of the Reporting Persons may have been deemed to have beneficially owned 509,464 shares of Class A Common Stock, par value $0.01 per share ("Class A Common Stock"), of Evolent Health, Inc. (the "Issuer"). All securities reported in this Schedule 13G were directly held by Cadian Master Fund L.P. and Cadian Opportunities Master Fund LP (collectively, the "Advisory Clients"), advisory clients of Cadian Capital Management, LP (the "Adviser"). Pursuant to Investment Management Agreements between the Advisory Clients and the Adviser, the Adviser exercises exclusive voting and investment power over securities directly held by the Advisory Clients. Cadian Capital Management GP, LLC is the general partner of the Adviser. Eric Bannasch is the sole managing member of Cadian Capital Management GP, LLC.
(b)
Percent of class:
As of September 30, 2026, each of the Reporting Persons may have been deemed to have beneficially owned approximately 0.5% of the shares of Class A Common Stock of the Issuer outstanding, based on 113,059,335 shares of Class A Common Stock outstanding as of August 1, 2026, as disclosed in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
As of September 30, 2026, each of the Reporting Persons may have been deemed to have had sole power to vote or to direct the vote of 0 shares of Class A Common Stock.
(ii) Shared power to vote or to direct the vote:
As of September 30, 2026, each of the Reporting Persons may have been deemed to have had shared power to vote or to direct the vote of 509,464 shares of Class A Common Stock.
(iii) Sole power to dispose or to direct the disposition of:
As of September 30, 2026, each of the Reporting Persons may have been deemed to have had sole power to dispose or to direct the disposition of 0 shares of Class A Common Stock.
(iv) Shared power to dispose or to direct the disposition of:
As of September 30, 2026, each of the Reporting Persons may have been deemed to have had shared power to dispose or to direct the disposition of 509,464 shares of Common Stock.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
The disclosure regarding the relationships among the Reporting Persons in Item 4 is incorporated by reference herein.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Cadian Capital Management, LP
Signature:
/s/ Eric Bannasch
Name/Title:
Eric Bannasch/Managing Member, Cadian Capital Management GP, LLC, its General Partner